Impact of glucagon-like peptide-1 receptor agonists on bowel preparation quality for colonoscopy in type 2 diabetes

Table 4 Association between glucagon-like peptide-1 receptor agonist subtype and the risk of inadequate bowel preparation

	Propensity matched patients (n = 133)
	Unadjusted OR (95%CI)	P value	Adjusted OR (95%CI)	P value
GLP-1RA
Dulaglutide 0.75 mg	Reference	0.587	Reference	0.410
Dulaglutide 1.5 mg	1.66 (0.67-4.14)	0.273	1.85 (0.72-4.72)	0.201
Liraglutide 3.6 mg/1 mL	4.13 (0.23-73.30)	0.334	4.72 (0.40-56.23)	0.220
Liraglutide 18 mg/3 mL	1.03 (0.18-5.83)	0.972	0.98 (0.14-6.78)	0.986

CI: Confidence interval; GLP-1RA: Glucagon-like peptide-1 receptor agonist; OR: Odds ratio.